Abstract: PO1690
Predictors of Functional Status Change in Patients with CKD Between Two Hip Fracture Events: A 6-Year Prospective Study
Session Information
- Advances in Geriatric Nephrology
October 22, 2020 | Location: On-Demand
Abstract Time: 10:00 AM - 12:00 PM
Category: Geriatric Nephrology
- 1100 Geriatric Nephrology
Authors
- Wu, Henry, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, United Kingdom
- Van Mierlo, Rene, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, United Kingdom
- Dhaygude, Ajay Prabhakar, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, United Kingdom
- Mitra, Sandip, The University of Manchester, Manchester, Manchester, United Kingdom
- Nixon, Andrew Christopher, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, United Kingdom
Background
Patients with chronic kidney disease (CKD) are susceptible to recurrent hip fractures (Hip#). Functional status decline after Hip# is transient, exacerbated by frailty, sarcopenia and co-morbidities. We studied the prognostic value of clinical and laboratory parameters for functional status change in CKD after recurrent Hip#.
Methods
Patients with CKD G3b-5 admitted with 2 separate Hip# events between June 2013 and Dec 2019 in a North West UK tertiary care hospital were included. Difference in Karnovsky Performance Status (KPS) Scale between 1st and 2nd Hip# admission determined functional status change. KPS is a linear scale between 0 (dead) and 100 (normally active). Parameters assessed include Clinical Frailty Scale (CFS), Hopkins Frailty Score (HFS), CKD FI-LAB, Sernbo Score, Charlson's Co-morbidity Index, Nottingham Hip Fracture Score, ASA Score and Abbreviated Mental Test Score. Differences in each parameter score between 1st and 2nd Hip# admission were recorded. ROC curve analyses was performed to assess discriminative ability between individual scoring tools.
Results
37 patients met inclusion criteria (F:M 1.8:1; mean age 84.5+10.2 yrs). 10 were receiving long-term dialysis, whilst non-dialysis CKD patients had a mean eGFR 33+15 mL/min/1.73m2. Mean age difference between Hip# is 1.4 yrs (p=0.032). Mean KPS difference between Hip# is -10.6 (p=0.028). AUC values from ROC analyses are shown in Table 1.
Conclusion
There was a significant decline in functional status between Hip#. Frailty assessment tools (CFS, HFS and CKD FI-LAB) had the best predictive performance for functional status change. Frailty measures may be utilized as risk prediction tools of functional status change from first Hip# admission. Further Research is needed on post-Hip# interventions that aim to maintain functional status and reduce subsequent fracture risk.
Table 1
Predictors | AUC Value (95%Cl) |
Clinical Frailty Scale | 0.96 (0.90-1.00) |
Hopkins Frailty Score | 0.95 (0.89-1.00) |
CKD FI-LAB | 0.91 (0.83-0.99) |
Sernbo Score | 0.85 (0.77-0.93) |
Charlson's Co-morbidity Index | 0.78 (0.69-0.88) |
Nottingham Hip Fracture Score | 0.74 (0.66-0.82) |
ASA Score | 0.67 (0.59-0.75) |
Abbreviated Mental Test Score | 0.56 (0.51-0.61) |
Funding
- Government Support - Non-U.S.